This inventor holds 3 USPTO granted patents. Top assignee: The University of Texas System. Active years: 1993-2010.
Location History:
- Sante Fe, TX (US) (1994)
- Santa Fe, TX (US) (1993 - 2010)
Company Filing History:
Years Active: 1993-2010
Title: Innovations and Contributions of Gary R Klimpel
Introduction
Gary R Klimpel is a notable inventor based in Santa Fe, TX (US). He has made significant contributions to the field of microbiology and immunology, holding a total of 3 patents. His work primarily focuses on developing methods and compositions for vaccination against enterobacteriaceae bacteria.
Latest Patents
One of his latest patents is titled "Methods and compositions for vaccination against or involving enterobacteriaceae bacteria." This invention concerns the use of methods and compositions to prophylactically or therapeutically vaccinate a subject against a pathogen or disease. The embodiments of this invention include the production of an attenuated bacterium from the family Enterobacteriaceae with a non-functional lipoprotein for use as a vaccine or as a vaccine vector for delivering antigens to a subject to be vaccinated. In certain embodiments, a bacterium of the Enterobacteriaceae family lacking a wild type lipoprotein may be produced and used as a vaccine or vaccine vector.
Another significant patent is "Method of using cytokine receptors on microorganisms." This patent discusses cytokine receptors for tumor necrosis factor e, which are found on microorganisms. When bound with exogenous TNF.alpha., these receptors may enhance the response of natural killer cells activated by the microorganisms or increase TNF.alpha. production by peripheral blood lymphocytes treated with the microorganisms. Microorganisms with receptor-bound exogenous TNF.alpha. exhibit enhanced cellular invasion ability, which may alter the immune response to them. Clinical and pharmaceutical applications of these discoveries are also provided.
Career Highlights
Gary R Klimpel is affiliated with the University of Texas System, where he continues to contribute to research and innovation in his field. His work has implications for vaccine development and understanding immune responses, making him a valuable asset to the scientific community.
Collaborations
He has collaborated with notable colleagues such as David W Niesel and Ashok K Chopra, further enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Gary R Klimpel's innovative work in the field of microbiology and immunology has led to significant advancements in vaccination methods. His contributions are vital for the ongoing development of effective vaccines against enterobacteriaceae bacteria.
